Literature DB >> 29437534

Oncolytic Virotherapy for Malignant Gliomas.

Peter A Forsyth1, Daniel Abate-Daga1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29437534     DOI： 10.1200/JCO.2017.77.3192

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Authors:  Robin A Buerki; Zinal S Chheda; Hideho Okada
Journal:  Clin Cancer Res       Date:  2018-06-05       Impact factor: 12.531

2.  Enterovirus A71 Oncolysis of Malignant Gliomas.

Authors:  Xiaowei Zhang; Hanzhong Wang; Yuhan Sun; Mi Qi; Wei Li; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  Mol Ther       Date:  2020-04-14       Impact factor: 11.454

3.  An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.

Authors:  Lynette M Phillips; Shoudong Li; Joy Gumin; Marc Daou; Daniel Ledbetter; Jing Yang; Sanjay Singh; Brittany C Parker Kerrigan; Anwar Hossain; Ying Yuan; Candelaria Gomez-Manzano; Juan Fueyo; Frederick F Lang
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

Review 4.  Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology.

Authors:  Benjamin B Kasten; Neha Udayakumar; Jianmei W Leavenworth; Anna M Wu; Suzanne E Lapi; Jonathan E McConathy; Anna G Sorace; Asim K Bag; James M Markert; Jason M Warram
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 5.  Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy.

Authors:  Jang Hyun Park; Heung Kyu Lee
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.